ORIFARM PI A/S: Financial statements 2013
CVR: 27347177
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -30,000 and a net result of DKK 18,511,000 compared with DKK 17,551,000 the year before. Equity in the 2013 report amounted to DKK 42,598,000. The solvency ratio was 64.8%.
- Gross Profit
- DKK -30,000
- Profit/Loss
- DKK 18,511,000
- Equity
- DKK 42,598,000
- Total Assets
- DKK 65,718,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -30K | 18.5M | 42.6M | - |
| 2012 | - | -46K | 17.6M | 25.6M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
ORIFARM PI A/S has published its annual report for 2012. Gross profit came to DKK -46,000, and the net result was DKK 17,551,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.